BioSpace News Archive

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics, will present at the Stifel 2019 Healthcare Conference

Revenues reached a record $1.5 million, up 101% over the third quarter of 2018 and up 28% over the second quarter of 2019

Aurinia Pharmaceuticals Inc. announced the appointment of Ms. Jill Leversage to its Board of Directors and the resignation of Dr. Hyeuk Joon Lee.

Amedisys, Inc. announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2019 Jefferies London Healthcare Conference in London, England on Wednesday, November 20, 2019.

Company Advancing ALPN-101 into a Phase 1/2 Acute Graft versus Host Disease Study (BALANCE)

Eton Pharmaceuticals, Inc announced it has entered into a $10 million debt facility with SWK Holdings Corporation.

Trevi Therapeutics, Inc. announced that management will present a Company overview, as well as host investor meetings, at the Stifel 2019 Healthcare Conference